Co-morbidities

Mohammed El-Sheikh , Nora Olsen El Caidi , Aginsha Kandiah , et al

Read time: 20m 9s

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2025 – Day Two

Nisha Bansal, Antonio Ceriello, David Wheeler, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2025 – Day One

Nisha Bansal, Antonio Ceriello, David Wheeler, et al

Dinesh Khullar , Anish Kumar Gupta , Kulwant Singh

Read time: 21m 40s

Laibah Arshad Khan , Adeena Jamil , Stephen J Greene , et al

Read time: 37m 48s
AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s
AHA 24: The EMPEROR-Preserved Trial

Andrew JS Coats

Watch time: 4m 41s

Muthiah Vaduganathan, Orly Vardeny et al

AHA 24 Late-Breaking Discussion: REALIZE-K

Harriette Van Spall, Mikhail Kosiborod

Watch time: 22m 30s

Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan

Read time: 19m 41s

Aleksandra Bykova , Maria Serova , Maria Chashkina , et al

Read time: 22m 11s
ESC 24: MRAs in Heart Failure

Watch time: 5m 46s

Carolyn Lam, Scott Solomon, John JV McMurray, et al

Watch time: 1:02:16 (5 videos)

Muthiah Vaduganathan

Sydney Tang et al

Andrew JS Coats, Stefan Anker

David K Ryan , Debasish Banerjee , Fadi Jouhra

Read time: 10m
Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Muthiah Vaduganathan, Orly Vardeny et al

Giulio Balestrieri , Raul Limonta , Enrico Ponti , et al

Read time: 18m 10s

Broadcast

Heart Failure
Hyperkalaemia in Cardiorenal Disease

Shelley Zieroth, Clara Bonanad Lozano , Andrew Frankel, et al

Watch time: 1h 34m 52s

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.

Media

HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal

Watch time: 8m 47s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day Two

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day One

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Shelley Zieroth

Watch time: 3m 59s (1 video)

Broadcast

Heart Failure
Hyperkalaemia in Cardiorenal Disease

Shelley Zieroth, Clara Bonanad Lozano , Andrew Frankel, et al

Watch time: 1h 34m 52s

Carolyn Lam, Scott Solomon, John JV McMurray, et al

Watch time: 1:02:16 (5 videos)
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s

Andrew JS Coats, Stefan Anker

Media

Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s
ESC 22: EMPEROR-POOLED: Clinical Benefits of SGLT2i in Heart Failure

Faiez Zannad

Watch time: 4m 44s
ESC 22: EMPEROR-Preserved & DELIVER Meta-Analysis: SGLT2is in HF

Muthiah Vaduganathan

Watch time: 5m 1s
AHA 22: Efficacy of Empagliflozin in Black vs White Pts With Heart Failure

Subodh Verma

Watch time: 5m
ACC 23: Mechanism of Benefit for Dapagliflozin in HFpEF

Barry Borlaug

Watch time: 5m 21s
HFA 23: DAPA-HF and DELIVER: KCCQ in Pts with Varying Ejection Fraction

Ankeet Bhatt

Watch time: 4m 45s
HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal

Watch time: 8m 47s

Harriette Van Spall, Stefan James

Watch time: 14m 14s
ESC 24: MRAs in Heart Failure

Watch time: 5m 46s
AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2025 – Day Two

Nisha Bansal, Antonio Ceriello, David Wheeler, et al

Articles

The True Obesity Paradox: Obese and Malnourished?

Mohammed El-Sheikh

,

Nora Olsen El Caidi

,

Aginsha Kandiah

,

et al

Published:

19 February 2025

Citation:

Cardiac Failure Review 2025;11:e03.

DOI:

https://doi.org/10.15420/cfr.2024.35
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 620
  • Downloads: Downloads 38
  • Read time: 20m 9s

Finerenone: Will It Be a Game-changer?

Dinesh Khullar

,

Anish Kumar Gupta

,

Kulwant Singh

,

Published:

23 December 2024

Citation:

Cardiac Failure Review 2024;10:e19.

DOI:

https://doi.org/10.15420/cfr.2024.11
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3919
  • Downloads: Downloads 225
  • Citations: 1
  • Read time: 21m 40s

Aldosterone and Potassium in Heart Failure

Laibah Arshad Khan

,

Adeena Jamil

,

Stephen J Greene

,

Muhammad Shahzeb Khan

,

Javed Butler

,

Published:

20 December 2024

Citation:

Cardiac Failure Review 2024;10:e18.

DOI:

https://doi.org/10.15420/cfr.2024.09
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1931
  • Downloads: Downloads 186
  • Citations: 1
  • Read time: 37m 48s

Mineralocorticoid Receptor Antagonists in Heart Failure

Rishi Sethi

,

Pravesh Vishwakarma

,

Akshyaya Pradhan

,

Published:

12 November 2024

Citation:

Cardiac Failure Review 2024;10:e15.

DOI:

https://doi.org/10.15420/cfr.2024.10
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1912
  • Downloads: Downloads 202
  • Citations: 1
  • Read time: 19m 41s